Cargando…
Novel Therapeutic Approaches for the Treatment of Retinal Degenerative Diseases: Focus on CRISPR/Cas-Based Gene Editing
Inherited retinal diseases encompass a highly heterogenous group of disorders caused by a wide range of genetic variants and with diverse clinical symptoms that converge in the common trait of retinal degeneration. Indeed, mutations in over 270 genes have been associated with some form of retinal de...
Autores principales: | Gallego, Carmen, Gonçalves, Manuel A. F. V., Wijnholds, Jan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7468381/ https://www.ncbi.nlm.nih.gov/pubmed/32973430 http://dx.doi.org/10.3389/fnins.2020.00838 |
Ejemplares similares
-
Comparison of CRISPR/Cas Endonucleases for in vivo Retinal Gene Editing
por: Li, Fan, et al.
Publicado: (2020) -
An optimized CRISPR/Cas9 approach for precise genome editing in neurons
por: Fang, Huaqiang, et al.
Publicado: (2021) -
Editing the Central Nervous System Through CRISPR/Cas9 Systems
por: Cota-Coronado, Agustin, et al.
Publicado: (2019) -
Genomic Editing of Non-Coding RNA Genes with CRISPR/Cas9 Ushers in a Potential Novel Approach to Study and Treat Schizophrenia
por: Zhuo, Chuanjun, et al.
Publicado: (2017) -
Opportunities for CRISPR/Cas9 Gene Editing in Retinal Regeneration Research
por: Campbell, Leah J., et al.
Publicado: (2017)